Follow
Joshua M DiNapoli
Joshua M DiNapoli
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens
JM DiNapoli, A Kotelkin, L Yang, S Elankumaran, BR Murphy, SK Samal, ...
Proceedings of the National Academy of Sciences 104 (23), 9788-9793, 2007
1682007
Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization
C Le Nouën, LG Brock, C Luongo, T McCarty, L Yang, M Mehedi, ...
Proceedings of the National Academy of Sciences 111 (36), 13169-13174, 2014
1282014
Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly …
JM DiNapoli, L Yang, A Suguitan Jr, S Elankumaran, DW Dorward, ...
Journal of Virology 81 (21), 11560-11568, 2007
1222007
CX3CR1 is expressed in differentiated human ciliated airway cells and co-localizes with respiratory syncytial virus on cilia in a G protein-dependent manner
KI Jeong, PA Piepenhagen, M Kishko, JM DiNapoli, RP Groppo, L Zhang, ...
PloS one 10 (6), e0130517, 2015
1152015
Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge …
JM DiNapoli, B Nayak, L Yang, BW Finneyfrock, A Cook, H Andersen, ...
Journal of virology 84 (3), 1489-1503, 2010
1082010
Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
JM DiNapoli, L Yang, SK Samal, BR Murphy, PL Collins, A Bukreyev
Vaccine 29 (1), 17-25, 2010
932010
Computationally optimized broadly reactive hemagglutinin elicits hemagglutination inhibition antibodies against a panel of H3N2 influenza virus cocirculating variants
TM Wong, JD Allen, AG Bebin-Blackwell, DM Carter, T Alefantis, ...
Journal of virology 91 (24), 10.1128/jvi. 01581-17, 2017
882017
Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets preimmune to historical H1N1 influenza viruses
DM Carter, CA Darby, SK Johnson, MA Carlock, GA Kirchenbaum, ...
Journal of virology 91 (24), 10.1128/jvi. 01283-17, 2017
642017
Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
AA Bukreyev, JM DiNapoli, L Yang, BR Murphy, PL Collins
Virology 399 (2), 290-298, 2010
632010
Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity
B Nayak, S Kumar, JM DiNapoli, A Paldurai, DR Perez, PL Collins, ...
Journal of virology 84 (5), 2408-2420, 2010
572010
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
S Chivukula, T Plitnik, T Tibbitts, S Karve, A Dias, D Zhang, R Goldman, ...
npj Vaccines 6 (1), 153, 2021
522021
Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
JM DiNapoli, JM Ward, L Cheng, L Yang, S Elankumaran, BR Murphy, ...
Vaccine 27 (10), 1530-1539, 2009
482009
Development of a Pan-H1 influenza vaccine
N Darricarrère, S Pougatcheva, X Duan, RS Rudicell, TH Chou, ...
Journal of virology 92 (22), 10.1128/jvi. 01349-18, 2018
452018
Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure
C Le Nouën, T McCarty, M Brown, ML Smith, R Lleras, MA Dolan, ...
Proceedings of the National Academy of Sciences 114 (3), E386-E395, 2017
442017
Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model
S Delagrave, H Hernandez, C Zhou, JF Hamberger, ST Mundle, J Catalan, ...
Public Library of Science 7 (10), e46714, 2012
442012
Elicitation of protective antibodies against 20 years of future H3N2 cocirculating influenza virus variants in ferrets preimmune to historical H3N2 influenza viruses
JD Allen, H Jang, J DiNapoli, H Kleanthous, TM Ross
Journal of virology 93 (3), 10.1128/jvi. 00946-18, 2019
412019
Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or …
JM DiNapoli, BR Murphy, PL Collins, A Bukreyev
Virology journal 5, 1-8, 2008
412008
Comparison of adjuvants to optimize influenza neutralizing antibody responses
RS Rudicell, M Garinot, M Kanekiyo, HD Kamp, K Swanson, T Chou, ...
Vaccine 37 (42), 6208-6220, 2019
242019
A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains
TM Ross, J DiNapoli, M Giel-Moloney, CE Bloom, K Bertran, C Balzli, ...
Vaccine 37 (17), 2369-2376, 2019
242019
Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates
KV Kalnin, T Plitnik, M Kishko, J Zhang, D Zhang, A Beauvais, ...
BioRxiv, 2020.10. 14.337535, 2020
202020
The system can't perform the operation now. Try again later.
Articles 1–20